DZ2944A1 - Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant. - Google Patents

Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.

Info

Publication number
DZ2944A1
DZ2944A1 DZ990244A DZ990244A DZ2944A1 DZ 2944 A1 DZ2944 A1 DZ 2944A1 DZ 990244 A DZ990244 A DZ 990244A DZ 990244 A DZ990244 A DZ 990244A DZ 2944 A1 DZ2944 A1 DZ 2944A1
Authority
DZ
Algeria
Prior art keywords
azalides
preparation
new
pharmaceutical compositions
compositions containing
Prior art date
Application number
DZ990244A
Other languages
English (en)
French (fr)
Inventor
Robert John Rafka
Barry James Morton
Colman Brendan Ragan
Peter Bertinato
John Philip Dirlam
Alan Elwood Blize
Cari Bernard Ziegler
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22327457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DZ2944(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DZ2944A1 publication Critical patent/DZ2944A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DZ990244A 1998-11-20 1999-11-17 Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant. DZ2944A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10939998P 1998-11-20 1998-11-20

Publications (1)

Publication Number Publication Date
DZ2944A1 true DZ2944A1 (fr) 2004-03-15

Family

ID=22327457

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ990244A DZ2944A1 (fr) 1998-11-20 1999-11-17 Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.

Country Status (46)

Country Link
US (1) US6329345B1 (da)
EP (1) EP1131331B1 (da)
JP (1) JP3842973B2 (da)
KR (1) KR100477774B1 (da)
CN (2) CN101367853A (da)
AP (1) AP2001002142A0 (da)
AR (3) AR019496A1 (da)
AT (1) ATE260927T1 (da)
AU (1) AU766106B2 (da)
BG (1) BG65107B1 (da)
BR (2) BRPI9915480B8 (da)
CA (1) CA2351429C (da)
CO (1) CO5380019A1 (da)
CZ (1) CZ303099B6 (da)
DE (1) DE69915336T2 (da)
DK (1) DK1131331T3 (da)
DZ (1) DZ2944A1 (da)
EA (2) EA009729B1 (da)
EG (1) EG23823A (da)
ES (1) ES2216581T3 (da)
GT (1) GT199900198A (da)
HK (1) HK1041269A1 (da)
HR (1) HRP20010374B1 (da)
HU (1) HU229008B1 (da)
ID (1) ID28548A (da)
IL (3) IL142631A0 (da)
IS (1) IS2350B (da)
MA (1) MA26707A1 (da)
ME (1) ME00467B (da)
MY (1) MY122353A (da)
NO (3) NO319796B1 (da)
NZ (1) NZ511199A (da)
OA (1) OA11713A (da)
PA (1) PA8485601A1 (da)
PE (1) PE20001378A1 (da)
PL (1) PL198580B1 (da)
PT (1) PT1131331E (da)
RS (1) RS50302B (da)
SI (1) SI1131331T1 (da)
SK (1) SK284607B6 (da)
TN (1) TNSN99214A1 (da)
TW (2) TWI243825B (da)
UA (1) UA70972C2 (da)
UY (1) UY25805A1 (da)
WO (1) WO2000031097A1 (da)
ZA (1) ZA200104019B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків
CN1351608A (zh) * 1999-05-24 2002-05-29 辉瑞产品公司 13－甲基红霉素衍生物
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
BR0110382A (pt) * 2000-04-27 2003-06-24 Pfizer Prod Inc Utilização de composições antibióticas azalida para o tratamento ou prevenção de uma infecção causada por bactérias ou protozoários em mamìferos
MXPA03009786A (es) * 2001-04-27 2004-01-29 Pfizer Prod Inc Procedimiento para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-sustituidos.
WO2003014136A1 (en) * 2001-08-08 2003-02-20 Taisho Pharmaceutical Co., Ltd. 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
MXPA06005639A (es) * 2003-11-21 2006-08-17 Pfizer Prod Inc Adyuvante antimicrobiano.
EP1985620A4 (en) * 2006-02-07 2012-08-15 Taisho Pharmaceutical Co Ltd COMPOUND 10a-AZALIDE
US8293715B2 (en) 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
JPWO2009139181A1 (ja) 2008-05-15 2011-09-15 大正製薬株式会社 ４員環構造を有する１０ａ−アザライド化合物
WO2012038372A1 (en) * 2010-09-20 2012-03-29 Novartis Ag Novel process for the preparation of 9-deoxo-9a-aza- 9a-homoerythromycin a modified in the c-4'' of the cladinose ring by an epoxide group
CN102295672B (zh) * 2011-07-13 2014-06-04 武汉回盛生物科技有限公司 一种泰拉菌素的合成方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
WO2015014907A1 (en) * 2013-07-31 2015-02-05 Farma Grs, D.O.O. Process for preparation of tulathromycin
CN109748942A (zh) * 2014-05-16 2019-05-14 普莱柯生物工程股份有限公司 一种大环内酯类化合物
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
SG11202105228SA (en) * 2018-11-19 2021-06-29 Zikani Therapeutics Inc C11-cyclic substituted 13-membered macrolides and uses thereof
CN113573779A (zh) * 2018-11-19 2021-10-29 齐卡尼治疗股份有限公司 C10-亚烷基取代的13元大环内酯及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
YU44599B (en) * 1986-09-12 1990-10-31 Pliva Pharm & Chem Works Process for preparing complex of n-methyl-11-aza-10-deoxo-10-dihydroeritromicine a and 11-aza-10-deoxo-10-dihydroeritromicine a with metals
US5106961A (en) 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
HRP931480B1 (en) * 1993-12-08 1997-08-31 Sour Pliva 9a-N-(N'-CARBAMONYL) and 9a-N-(N'-THIOCARBAMONYL) DERIVATES OF 9-DEOXO-9a-HOMOERYTHROMYCIN A
GB2327084A (en) * 1997-07-08 1999-01-13 Merck & Co Inc 9a-Aza-3-ketolide antibiotics
UA70972C2 (uk) * 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
NO20012464D0 (no) 2001-05-18
EP1131331A1 (en) 2001-09-12
NO20050904L (no) 2001-07-17
CZ20011754A3 (cs) 2002-03-13
EG23823A (en) 2007-09-19
BRPI9915480B1 (pt) 2015-12-29
NO319796B1 (no) 2005-09-19
SK6632001A3 (en) 2002-07-02
EA200400701A1 (ru) 2004-12-30
DE69915336D1 (de) 2004-04-08
US6329345B1 (en) 2001-12-11
HUP0104313A2 (hu) 2002-02-28
YU33401A (sh) 2004-05-12
AR059523A2 (es) 2008-04-09
KR100477774B1 (ko) 2005-03-21
RS50302B (sr) 2009-09-08
KR20010086043A (ko) 2001-09-07
IS5918A (is) 2001-04-17
EP1131331B1 (en) 2004-03-03
HRP20010374A2 (en) 2002-06-30
SI1131331T1 (en) 2004-08-31
NZ511199A (en) 2003-08-29
MA26707A1 (fr) 2004-12-20
ATE260927T1 (de) 2004-03-15
AU1068600A (en) 2000-06-13
TWI243825B (en) 2005-11-21
UA70972C2 (uk) 2004-11-15
ES2216581T3 (es) 2004-10-16
HRP20010374B1 (en) 2006-09-30
AR019496A1 (es) 2002-02-20
PE20001378A1 (es) 2000-12-14
IL189430A (en) 2010-05-31
TWI243824B (en) 2005-11-21
ID28548A (id) 2001-05-31
CZ303099B6 (cs) 2012-04-04
AR059524A2 (es) 2008-04-09
AU766106B2 (en) 2003-10-09
BG105600A (en) 2001-12-29
MY122353A (en) 2006-04-29
JP2002530422A (ja) 2002-09-17
ME00467B (me) 2011-10-10
CA2351429A1 (en) 2000-06-02
CA2351429C (en) 2005-07-12
NO20012464L (no) 2001-07-17
JP3842973B2 (ja) 2006-11-08
EA005156B1 (ru) 2004-12-30
DK1131331T3 (da) 2004-06-14
ZA200104019B (en) 2002-06-17
BRPI9915480B8 (pt) 2022-05-10
PL198580B1 (pl) 2008-06-30
SK284607B6 (sk) 2005-07-01
NO20050893L (no) 2001-07-17
CN101367853A (zh) 2009-02-18
AP2001002142A0 (en) 2001-05-09
IL142631A (en) 2010-05-31
TW200404077A (en) 2004-03-16
PT1131331E (pt) 2004-06-30
TNSN99214A1 (fr) 2005-11-10
HUP0104313A3 (en) 2003-12-29
IS2350B (is) 2008-04-15
CN1326460A (zh) 2001-12-12
CO5380019A1 (es) 2004-03-31
HK1041269A1 (zh) 2002-07-05
PL347784A1 (en) 2002-04-22
UY25805A1 (es) 2001-08-27
PA8485601A1 (es) 2000-09-29
DE69915336T2 (de) 2005-01-13
NO330249B1 (no) 2011-03-14
EA009729B1 (ru) 2008-02-28
WO2000031097A1 (en) 2000-06-02
BG65107B1 (bg) 2007-02-28
GT199900198A (es) 2001-05-11
NO329629B1 (no) 2010-11-22
EA200100416A1 (ru) 2001-10-22
OA11713A (en) 2005-01-25
IL142631A0 (en) 2002-03-10
BR9915480A (pt) 2001-07-31
HU229008B1 (en) 2013-07-29
IL189430A0 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
DZ2944A1 (fr) Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant.
MA26659A1 (fr) Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2891A1 (fr) Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr) 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3000A1 (fr) Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant.
DZ2963A1 (fr) Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr) Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3020A1 (fr) Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2889A1 (fr) 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2197A1 (fr) Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1957A1 (fr) Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr) Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2773A1 (fr) Pyrazolopyrimidinones nouvelles procédé pour leur préparation et compositions pharmaceutiques les contenant.
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3045A1 (fr) Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2128A1 (fr) Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2745A1 (fr) BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26551A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26686A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2866A1 (fr) 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2777A1 (fr) Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26465A1 (fr) Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26558A1 (fr) Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26490A1 (fr) Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.